| [1] | Yaxin CHEN, Wen GUO, Kaige LIU, Qian LI, Mingxin ZHANG. Diagnosis and treatment of cirrhotic portal hypertension with spontaneous portosystemic shunt: Current status and prospects[J]. Journal of Clinical Hepatology, 2025, 41(1): 176-182. doi: 10.12449/JCH250127 |
| [2] | Xinyi LI, Jiaojiao LI, Wei SUN. Establishment and evaluation of a nomogram prediction model for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2024, 40(8): 1605-1611. doi: 10.12449/JCH240816 |
| [3] | Lanjing WANG, Jianping QIN, Xin YAO, Qi QI, Lin LIU, Shanhong TANG. Construction of a risk prediction model for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatitis B cirrhosis and portal hypertension[J]. Journal of Clinical Hepatology, 2024, 40(6): 1149-1155. doi: 10.12449/JCH240613 |
| [4] | Hepatology International｜3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study[J]. Journal of Clinical Hepatology, 2024, 40(1): 128-128. doi: 10.12449/JCH2401.gwqkjpwzjj2 |
| [5] | Huan ZHANG, Tenglong XING, Pan ZHANG, Runrun SHANG, Mingmei WANG, Yuying ZHAO, Wanbo XU. Association between spontaneous portosystemic shunt and hepatorenal syndrome in liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2824-2830. doi: 10.3969/j.issn.1001-5256.2023.12.012 |
| [6] | Hepatology｜Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS[J]. Journal of Clinical Hepatology, 2022, 38(9): 2187-2187. doi: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj6 |
| [7] | Hepatology｜Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model[J]. Journal of Clinical Hepatology, 2022, 38(9): 1973-1973. doi: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj1 |
| [8] | Xue LI, Ying TU, Bin TANG, Xin YAO, Hao LI, Shanhong TANG. Research advances in cirrhotic portal hypertension with spontaneous portosystemic shunt[J]. Journal of Clinical Hepatology, 2021, 37(10): 2435-2438. doi: 10.3969/j.issn.1001-5256.2021.10.037 |
| [9] | Gonghai CHEN, Guangchuan WANG, Chunqing ZHANG. Current status of research on hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2021, 37(5): 1201-1204. doi: 10.3969/j.issn.1001-5256.2021.05.047 |
| [10] | Wang Zhong, Yue ZhenDong, Zhao HongWei, Wang Lei, Fan ZhenHua, Wu YiFan, Dong ChengBin, Zhang Yu, Liu FuQuan. Value of indocyanine green retention rate at 15 minutes in predicting the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in liver cancer patients with portal hypertension[J]. Journal of Clinical Hepatology, 2020, 36(9): 1994-1997. doi: 10.3969/j.issn.1001-5256.2020.09.017 |
| [11] | Wang Zhong, Liu FuQuan. Research advances in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(12): 2824-2827. doi: 10.3969/j.issn.1001-5256.2019.12.040 |
| [12] | He ChuangYe, Chen Hui, Lyu Yong, Xia DongDong, Yu TianLei, Yuan XuLong, Li Kai, Wang ZhengYu, Niu Jing, Bai Wei, Guo WenGang, Tie Jun, Yin ZhanXin, Han GuoHong. Safety and efficacy of flow-reducing stent in treatment of recurrent or persistent hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(8): 1719-1722. doi: 10.3969/j.issn.1001-5256.2019.08.014 |
| [13] | Hu WenYan, Rao ChunYan, Liu HuaBao, Wang YaNan. A case of spontaneous portosystemic shunt with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2019, 35(3): 611-612. doi: 10.3969/j.issn.1001-5256.2019.03.033 |
| [14] | Jiang MingYuan, Huang Hua, Lu MingLiang, Lin FanYu, Zhang YingYuan. Application of anticoagulants after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(10): 2241-2244. doi: 10.3969/j.issn.1001-5256.2018.10.040 |
| [17] | Niu Meng, Sun Jun, Xu Ke, Zhong HongShan. Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China[J]. Journal of Clinical Hepatology, 2016, 32(2): 230-233. doi: 10.3969/j.issn.1001-5256.2016.02.005 |
| [18] | Ren ShuYao, Chen Hui, Lu: Yong, Wang ZhengYu, Niu Jing, Yin ZhanXin, He ChuangYe, Guo WenGang, Han GuoHong. Hepatic myelopathy after transjugular intrahepatic portosystemic shunt:natural course,survival analysis,and treatment[J]. Journal of Clinical Hepatology, 2016, 32(6): 1112-1117. doi: 10.3969/j.issn.1001-5256.2016.06.018 |
| [19] | Wu WenBin, Han GuoHong. Embolization of spontaneous portosystemic shunt for cirrhotic patients with portal hypertension: a review of current status[J]. Journal of Clinical Hepatology, 2015, 31(9): 1528-1531. doi: 10.3969/j.issn.1001-5256.2015.09.042 |
DownLoad: